This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

UBS: 6 Specialty Pharma Picks to Watch

Auxilium Pharmaceuticals (AUXL) operates as a specialty biopharmaceutical company. It has been given a buy rating by UBS Investment Research. Despite the new competition in the testosterone market, Testim is expected to continue growing due to its patent protection. Xiaflex is expected to pick up improved reimbursement by 2016 and is also patent protected.

UBS is of the opinion that the assets of the company will be able to fit into a larger company in the consolidating sector. Shares of Auxilium are currently trading at $20 per share and are expected to reach a target price of $26, indicating a potential upside of 30%. George Soros initiated a brand new position in AUXL during the third quarter.

This commentary comes from an independent investor or market observer as part of TheStreet guest contributor program. The views expressed are those of the author and do not necessarily represent the views of TheStreet or its management.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
WCRX $0.00 0.00%
AGN $240.22 1.21%
AUXL $36.47 -0.16%
ALKS $62.26 0.00%
ENDP $93.27 0.00%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs